News roundup Tuesday, December 21

Invent Medic increases its sales focus and implements cost savings. Read more.

is carrying out a rights issue of SEK 66,9 million secured at 91 percent ahead of the phase IIb study in RA. Read more.

Gedea Biotech receives funding for microbiome research projects at the Center for Translational Microbiome Research at Karolinska Institutet. Read more.

AroCell is part of a collaboration with ZECEN Biotech for distribution in China. Read more.

PainDrainer has raised SEK 12,5 million to fully focus on the commercialization phase of its pain coach PainDrainer. Read more. One of the participants in the issue is Almi Invest. Read more.

RaySearch Laboratories launches a new version of RayCare. Read more.

Lumito announces the outcome of the rights issue. Read more.

Realheart has been granted an additional SEK 200 in grants from Vinnova within the framework of the call for proposals Medtech4Health: Competence enhancement in small businesses. Read more.

AstraZeneca announces that Ultomiris accepted for so-called FDA Priority Review. Read more.

Autopsy receives orders regarding a EITRE 8 NILsystem from a customer in Asia. Read more.

EXACT Therapeutics has received 7,4 million Norwegian kroner to further develop ATC. Read more.

Immunicums CEO summarizes the year and announces upcoming shareholder event to present clinical pipeline strategy. Read more.

SpectraCure provides status updates regarding patent applications. Read more.

Nightingale Health preventive health service has been launched at Shin-Oyama City Hospital in Japan. Read more.

Geert Nygaard has taken up the position as Managing Director of Glycorex Transplant. Read more.

Curasight reciting Hanne Damgaard Jensen as Chief Development Officer. Read more.

William Cronin will leave the role as CEO of Dignity in connection with the Annual General Meeting in May 2022. Read more.

ExpreS2ion Biotech appoints Dr. Mattis F. Ranthe to the Chief Medical Officer. Read more.

Brighter has received positive feedback for Activist in a user survey. Read more.

Genetic Analysis summarizing 2021. Read more.

Inhalation Sciences Sweden publishes a video summary of 2021. Read more.

Aqilion presents the nomination committee ahead of the 2022 Annual General Meeting. Read more.

Emplicure appoints a nomination committee. Read more.

Faron Pharmaceuticals publishes financial calendar for 2022. Read more.

iCellate provides an update regarding the ELEVATE project. Read more.

Notices of general meetings:

Abliva

Communiqués:

AcouBlack  Polymer Factory

News received since yesterday lunch:

Abliva decided on a directed issue of convertibles totaling SEK 26 million. Read more.

Klaria has started a clinical study with Naloxone Alginate Film and the first group of study participants have received their first doses. Read more.

BrainCool has obtained GMP certificate from FDA for the manufacture of disposable catheters in the product RhinoChill. Read more.

Pharmacologist and Codonics has expanded the existing agreement to include the sale of WasteLog and related services to the Middle East region. Read more.

Qlife has signed an agreement with FIND about a funding of 3,45 million USD for a 12-month project with the goal of developing a new two-in-one test for the detection of influenza and SARS-CoV-2 virus in decentralized healthcare settings. Read more.

AddLife has signed an agreement to acquire Telia Health Monitoring. Read more. AddLife's share is moved to Nasdaq Stockholm Large Cap starting from January 3, 2022. Read more.

QuiaPEG announced that the company will receive SEK 7 million through the exercise of warrants and a directed new share issue. Read more.

Amniotic has joined in Vinnova-funded 'CAMP' to improve lung transplant outcomes with PulmoStem. Read more.

Scandinavian ChemoTech has signed an agreement that enables an increased pace for implementation of the new strategy through loans from two lenders of a maximum of SEK 10 million. Read more.

PExAs vd Erik Ekbo has notified the board of his resignation and that he wishes to terminate his employment as CEO of the company no later than March 31, 2022. Read more.

Medicover has successfully completed its second Shuldschein issuance, a German debt instrument for private placement, raising EUR 277 million. Read more.

SUFFER has appointed Matthew Lindon to Chief Scientific Officer. Read more.

Polymer Factory provided an update on financial targets for 2021. Read more.

Xbrane Biopharma will be moved up to Nasdaq Stockholm Mid Cap January 3, 2022. Read more.

iZafe Group has held a partner interview between Anders Segerstrom, CEO of iZafe Group and Geir Tore Jakobsen, CEO Hepro. Read more.

C-ROW has received an order from the Belgian company Ion Beam Applications SA regarding the delivery of the majority Catalyst and Sentinel 4DCT system, as well as a multi-year service agreement. Read more.

ADDvise Group published a prospectus and has applied for listing of bond loans on Nasdaq Stockholm. Read more.

Sects Nomination Committee appointed for the 2022 Annual General Meeting. Read more.

Nykode Therapeutics informed about insider trading. Read moreThe company also announced an increase in share capital. Read more.

This morning's winner: Nicoccino Holding 19,4%, PharmaLundensis 17,2%, Cessatech 10,5%, PolarCool 9,4%, Spago Nanomedical 6,1%

This morning's losers: Cyxone -27,5%, CS Medica -9,8%, Lumito -8,3%, Follicum -6,6%, Amniotics -6,5%

Index: OMXS30 2309 +1,05%, Healthcare +0,59%